Tuesday, September 4, 2018

DVAX: Dynavax Announces Publication of Preclinical Study of TLR9 Agonist in Lung Cancer

New alert via PocketInfo for DVAX:

Dynavax Announces Publication of Preclinical Study of TLR9 Agonist in Lung Cancer

Press Releases: http://investors.dynavax.com/newsevents.cfm
SEC Filings: http://investors.dynavax.com/sec.cfm
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8

No comments:

Post a Comment